TP53 and urinary bladder cancer: For our analysis, we focused on TP53 and KDM6A which are amongst the most frequently mutated tumor suppressors in bladder cancer, mutated in ~50% and~25% of bladder cancer cases, respectively (Cancer Genome Atlas Research Network, 2014; Guo et al., 2013; Van Allen et al., 2014).